Filing Details
- Accession Number:
- 0001181431-13-039430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-10 18:49:04
- Reporting Period:
- 2013-07-08
- Filing Date:
- 2013-07-10
- Accepted Time:
- 2013-07-10 18:49:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1365216 | Sucampo Pharmaceuticals Inc. | SCMP | Pharmaceutical Preparations (2834) | 133929237 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1384370 | Ryuji Ueno | 4520 East-West Highway Suite 300 Bethesda MD 20814 | Ceo, Chief Scientific Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2013-07-08 | 28,162 | $6.48 | 25,103,412 | No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
Class A Common Stock | Disposition | 2013-07-09 | 10,300 | $6.49 | 25,093,112 | No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 148,530 | Direct | |
Class A Common Stock | 60,357 | Indirect | By Wife |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by S&R Technology Holdings, LLC on August 29, 2012.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.38 to $6.66, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.39 to $6.57, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Dr. Ueno disclaims beneficial ownership of the reported securities.